New genotype–phenotype correlations and transcriptomic findings in limb-girdle muscular dystrophy R9
- 17 July 2025
- journal article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (8) , 516
Abstract
We aimed to comprehensively investigate the clinical, genetic, muscle imaging, and pathological characteristics of limb-girdle muscular dystrophy R9 (LGMDR9) in a large cohort of Chinese patients. In addition, we sought to delineate the muscle transcriptomic landscape of LGMDR9 which has not been investigated. In total, 44 genetically confirmed Chinese LGMDR9 patients were enrolled. They underwent a detailed clinical, imaging, and pathological assessment, followed by customized bioinformatics analyses of genome-wide transcriptome data. LGMDR9 patients presented with heterogeneous clinical manifestations, including hyper-creatine kinase-emia without weakness (n = 15), as well as mild (n = 11), moderate (n = 7), and severe (n = 11) weakness subgroups determined by hierarchical analysis. Eleven of the 35 pathogenic FKRP variants identified in our cohort were novel, with the c.545A > G variant being the most common found in 72.7% (32/44) patients. Hierarchical analysis revealed that 15 patients harboring null variants (frameshift, nonsense, and large deletions) exhibited a more severe phenotype compared to those with missense/inframe variants in FKRP. Muscle biopsy showed a dystrophic pattern in 19 patients, necrotizing myopathy in 5 patients, and mild myopathic changes in 9 patients. Muscle magnetic resonance imaging analysis showed a concentric pattern of fatty infiltration in 60.7% (17/28) patients. Transcriptomic profiling of 12 muscle samples showed significant upregulation of genes related to inflammation/immune response and extracellular matrix remodeling (P < 0.05). Furthermore, weighted gene co-expression network analysis identified a "turquoise" module enriched in immune cell proliferation and inflammatory markers, which were strongly correlated with histopathological inflammatory scores validated by immunohistochemical staining. Our findings indicate that null variants in FKRP may be associated with a severe phenotype. We also provide the first transcriptomic and experimental evidence of an immune-activated inflammatory microenvironment in LGMDR9 muscle tissue, which support the potential utility of immunomodulatory therapies in managing this condition.Keywords
Funding Information
- National Natural Science Foundation of China (82201553)
- Peking University Clinical Scientist Training Program (BMU2025PYJH039)
- National High Level Hospital Clinical Research Funding (2023HQ10)
This publication has 47 references indexed in Scilit:
- Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal StudyPLOS ONE, 2013
- Limb-girdle muscular dystrophy type 2I is not rare in TaiwanNeuromuscular Disorders, 2013
- Aberrant repair and fibrosis development in skeletal muscleSkeletal Muscle, 2011
- Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patientsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2IEuropean Journal of Paediatric Neurology, 2007
- Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2IVirchows Archiv, 2007
- A novel FKRP gene mutation in a Taiwanese patient with limb-girdle muscular dystrophy 2IBrain and Development, 2007
- The most common mutation inFKRP causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once and is present in Hutterites and other populationsHuman Mutation, 2004
- Limb-girdle muscular dystrophy 2I: phenotypic variability within a large consanguineous Bedouin family associated with a novel FKRP mutationEuropean Journal of Human Genetics, 2003
- Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotypeNeuromuscular Disorders, 2003